A leading global orphan drugmaker increases its market size by 40% with Indegene Analytics
A leading global orphan drugmaker increases its market size by 40% with Indegene Analytics
2 PagesA leading global orphan drugmaker boosted its market size by 40% using Indegene Analytics for a rare disease drug, addressing limited data access that hindered brand performance and market share growth. Challenges included spotting at-risk patients to tap untapped markets and gaining visibility on diagnosed/treated patients across HCPs. Indegene's software delivered a 3-step approach: leveraging patient data from IQVIA LAAD, Symphony, and CareSet; identifying diagnosed, treated, and at-risk patients via pre-defined business rules; and providing metric counts at the HCP level. This unlocked quick insights, enhancing targeting and performance.
